July 29 (Reuters) - Medical device maker Boston Scientific Corp reported a second-quarter loss on Wednesday, hurt by lower demand for specialty medical devices as patients continued to defer elective procedures during the COVID-19 pandemic.
Net loss attributable to Boston Scientific was $153 million, or 11 cents per share, in the quarter ended June 30, compared with net earnings of $154 million, or 11 cents per share, last year.
Sales fell to $2.00 billion from $2.63 billion.
Reporting by Trisha Roy and Mrinalika Roy in Bengaluru; Editing by Devika Syamnath
Our Standards: The Thomson Reuters Trust Principles.